Loading stock data…
USANA Health Sciences, Inc. (USNA)
$15.20+0.24 (+1.60%)
Market ClosedLast close Sep 8
USANA Health Sciences, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
USANA Health Sciences, Inc. in the Consumer Defensive sector is trading at $15.20 with a market capitalization of $247M. Wall Street consensus targets $25.00 (1 analysts), implying a +64.5% move over the next 12 months. The stock is currently near its 52-week low of $12.57, remaining 20.4% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 80 is overbought against a weak tape. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +64.5% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Overbought RSI 80 against a weak tape — risk of pullback
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $250.22M↑ | $226.20M↑ | $213.67M↓ | $235.85M |
| Gross Profit | — | $190.78M↑ | $176.79M↑ | $164.85M↓ | $185.66M |
| Operating Income | — | $13.87M↓ | $17.25M↑ | $1.22M↓ | $16.72M |
| Net Income | — | $6.96M↑ | -$1.77M↑ | -$6.52M↓ | $9.65M |
Peer Comparison
Fundamentals
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. Th...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$247.03M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.72
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-0.25%
Volume
Today's trading volume
242,058
Recent News
3 Reasons to Sell USNA and 1 Stock to Buy Instead
What a brutal six months it’s been for USANA. The stock has dropped 30.2% and now trades at $14.02, rattling many shareholders. This may have investors wondering how to approach the situation.
Reflecting On Personal Care Stocks’ Q2 Earnings: USANA (NYSE:USNA)
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the personal care stocks, including USANA (NYSE:USNA) and its peers.
1 Consumer Stock for Long-Term Investors and 2 We Question
Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. On the other hand, they usually underperform during bull runs, and this paradigm has rung true over the past six months as the sector’s -4.8% decline paled in comparison to the S&P 500’s 10.5% gain.
1 Oversold Stock Set for a Comeback and 2 We Avoid
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they’re witnessing fire sales or falling knives.
3 Small-Cap Stocks We Find Risky
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.